       
|
Learn
More...
Select a Disease Condition
|
 |
 |
Dhaka Stock Exchange Ranks Renata
Among Top 10 Performers
Based on Earnings Per
Share (EPS) in 2003, Renata ranks 6th among all listed Companies on the
Dhaka Stock Exchange(http://www.dsebd.org).
This information was published in Monthly Review
of the Dhaka Stock Exchange [December 2004, VOL 19, NO 12].
Readers may recall that
using the same criteria, Renata ranked 8th based on 2002 earnings.
The details released by the
Dhaka Stock Exchange
are as follows:
Performance of TOP 10 Companies
of DSE by Earning Per Share
| Sl.No. |
Name
of Companies |
Earning Per Share
|
| 1 |
Atlas
Bangladesh |
295.00
|
| 2 |
National
Tubes |
237.98
|
| 3 |
Bata
Shoe Bangladesh Ltd. |
224.60
|
| 4 |
Square
Pharmaceuticals |
224.55
|
| 5 |
Uttara
Bank Ltd. |
197.41
|
|
6 |
Renata
Limited |
189.22
|
| 7 |
Usmania
Glass Sheet Factory |
161.04
|
| 8 |
Padma
Oil Company |
159.20
|
| 9 |
United
Leasing Co. |
157.60
|
| 10 |
British
American Tobacco |
145.20
|
RENATA LIMITED
|
Year of Establishment |
|
1972 |
|
Date of Incorporation |
06 December, 1972 |
|
Year of Listing |
1979 |
|
Company Address |
House No.
450, Road No. 31, New DOHS, Mohakhali, Dhaka-1206 |
|
Share Office |
-do- |
|
Phone/Fax/E-Mail |
Phone: 8850918-9, 9860914-5
Fax: 8815210. Email:
info@renata-ltd.com |
|
Chairman
|
Syed Humayun
Kabir |
|
Managing Director
|
Syed S.
Kaiser Kabir |
|
Company Secretary |
Md. Shafiul
Alam |
|
Nature of Business |
Pharmaceuticals, Animal Health Medicine,
Nutritionals and Vaccines. |
|
Major Products |
Pharmaceuticals, Animal Health
Medicine, Nutritionals and Vaccines. |
|
Future Plan/Others |
Modernization of Production facilities |
|
No. of Shareholders (At Present) |
817 |
|
Share Holding Position (%) |
i) Sponsors- 51,
ii) Institutions- 14
iii) Foreigners- 21
iv) General Public- 9 |
| Capital Market Information |
|
|
Instrument
Code
|
RENETA |
|
Market Category |
A |
|
Face Value |
Tk.100
|
|
Market Lot |
5 |
|
Year End |
December |
|
Last Date of AGM
|
23/6/2004 |
|
Declared
Dividend (%)
|
50 (Cash)
20 (Stock) |
|
Current Market Price (30.12.2004) |
Tk.3200.00 |
|
Market Capitalisation on December, 2004 |
1785.17 mn |
Corporate Operational Results
Tk. in million
|
Particulars |
2003 |
2002 |
2001 |
2000 |
1999 |
|
No. of Shares |
0.46 |
0.46 |
0.46 |
0.46 |
0.46 |
|
Paid up Capital |
46.49 |
46.49 |
46.49 |
46.49 |
46.49 |
|
Share Holders Equity |
576.52 |
514.68 |
469.83 |
391.06 |
356.74 |
|
Total Assets |
862.71 |
746.47 |
730.82 |
626.48 |
560.27 |
|
Total Liabilities |
806.92 |
699.98 |
684.33 |
579.99 |
513.79 |
|
Reserve & Surplus |
411.89 |
400.05 |
351.36 |
284.80 |
261.19 |
|
Net Sales (Gross Profit) |
1,110.04 |
911.59 |
822.80 |
663.64 |
580.76 |
|
Profit Before Tax |
150.44 |
94.59 |
105.84 |
55.81 |
37.45 |
|
Net Profit After Tax |
105.56 |
72.56 |
69.35 |
37.56 |
23.68 |
|
Book Value Per Share |
1,005.98 |
560.52 |
855.80 |
712.62 |
661.83 |
|
Earning Per Share |
227.07 |
156.09 |
149.17 |
80.79 |
50.94 |
| %
of Dividend |
50.00 |
50.00 |
40.00 |
30.00 |
25.00 |
|
Bonus/Right |
20% |
- |
- |
- |
- |
|
|
